Xiao Leng

Xiao Leng

Auto-generated profile, based on publicly available information

Xiao Leng

Basic Medical College, Chengdu University of Traditional Chinese medicine, Chengdu, China; Center for Scientific Research, Chengdu Medical College, Chengdu, China

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 December 2016 in Journal of Immunology Research
Verified
Journal Article
Open access
PDF file
YZYan Zhou
Yan Zhou
XLXiao Leng
Xiao Leng
SLShasha Luo
Shasha Luo
ZSZhiwei Su
Zhiwei Su
XLXingyan Luo
Xingyan Luo
YWYantang Wang
Yantang Wang
It is well known that dendritic cells (DCs) play a pivotal role in triggering self-specific responses. Conversely, tolerogenic DCs (tolDCs), a specialized subset, induce tolerance and negatively regulate autoreactive responses. Tofacitinib, a Janus kinase inhibitor developed by Pfizer for treatment of rheumatoid arthritis, is probable to be a promising candidate for inducing tolDCs. The aims of this study were to evaluate the effectiveness of tolDCs induced by tofacitinib in a myelin oligodendrocyte glycoprotein- (MOG-) specific experimental autoimmune encephalomyelitis (EAE) model and to investigate their effects on Th17/Treg balance in the animal model of multiple sclerosis (MS). Our results revealed that tofacitinib-treated DCs maintained a steady semimature phenotype with a low level of proinflammatory cytokines and costimulatory molecules. DCs treated by tofacitinib also induced antigen-specific T cells hyporesponsiveness in a concentration-dependent manner. Upon intravenous injection into EAE mice, MOG pulsed tolDCs significantly dampened disease activity, and adoptive cell therapy (ACT) disturbed Th17/Treg balance with a remarkable decrease of Th1/Th17 cells and an increase in regulatory T cells (Tregs). Overall, DCs modified by tofacitinib exhibited a typical tolerogenic phenotype, and the antigen-specific tolDCs may represent a new avenue of research for the development of future clinical treatments for MS.

2 October 2024 in European Journal of Pharmacology
Verified
Journal Article
Closed access
XLXiao Leng
Xiao Leng
QLQirui Li
Qirui Li
WCWanqi Chen
Wanqi Chen
HFHengwei Feng
Hengwei Feng
LLLi Li
Li Li
FXFei Xie
Fei Xie

9 September 2022 in Pharmaceutical Biology
Verified
Journal Article
Open access
GZGan Zhang
Gan Zhang
XZXinying Zhu
Xinying Zhu
FYFan Yang
Fan Yang
JLJuan Li
Juan Li
XLXiao Leng
Xiao Leng
YWYantang Wang
Yantang Wang
The alkaloids of Narcissus tazetta L. var. Chinensis Roem (Amaryllidaceae) have antitumor and antiviral activities. However, the immunopharmacological effects of one of its constituents, pseudolyco...